Michael W Dunne

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

Christopher M O'Connor, C. O'connor, M. Fisher, 2003, JAMA.

Maraviroc for previously treated patients with R5 HIV-1 infection.

Anders Karlsson, Edwin DeJesus, Bonaventura Clotet, 2008, The New England journal of medicine.

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Bernard Hirschel, Adriano Lazzarin, B. Hirschel, 2008, The New England journal of medicine.